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background:  Coronary artery disease (CAD) is a frequent complication of HIV infection and patients with HIV are increasingly referred for 
percutaneous coronary intervention (PCI). Despite substantial cardiac morbidity, the angiographic pattern or burden of CAD and outcomes following 
PCI in HIV patients has not been well described.
methods: We followed 112 consecutive patients with HIV who underwent PCI from 1999 to 2011. Quantitative coronary angiographic (QCA) 
analysis was performed independently in all patients. We determined the 1-year incidence of clinical outcomes in this setting.
results: We identified 112 HIV patients with 164 lesions undergoing PCI during the study period. Patients with HIV were more frequently male 
(79%) and non-Caucasian (71%) with a mean age of 57 years. Patients were mostly treated with DES (59%). Most lesions displayed minimal 
calcification (67%), modest lesion length (16.6 mm±10.6), with a diameter stenosis of 69%, and an overall SYNTAX score of 13.5±8.9. At 1-year, 
the incidence of major adverse cardiac events was 28% (Figure). Similar clinical outcomes were observed for both BMS and DES treated patients 
(28.4% vs. 27.8%, P=0.95).
Conclusion: Although the angiographic pattern of CAD in HIV patients suggests a relatively low-risk phenotype, the risk for adverse events after PCI 
is significant. These findings suggest that atherosclerosis progression and restenosis is altered in the setting of HIV. 
